All Pharma News
price-trendAsk Us
Peptron`s PT105 established the bioequivalence with Takeda`s Leuplin

Peptron`s PT105 established the bioequivalence with Takeda`s Leuplin
PRNEWSWIRE
28 Nov 2022
Share Share
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC

Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
PRNEWSWIRE
16 Apr 2021
Share Share
Repurposing a diabetes drug to slow Parkinson’s

Repurposing a diabetes drug to slow Parkinson’s
Bradley J. Fikes FIERCE BIOTECH
23 Jul 2018
Share Share
New SR Exendin-4 Formulation proves effective against Parkinson`s

New SR Exendin-4 Formulation proves effective against Parkinson`s
BIOSPECTRUM
16 Jul 2018
Share Share
Peptron Expands Exclusive License with NIH to Support Developing SR-exenatide

Peptron Expands Exclusive License with NIH to Support Developing SR-exenatide
PR NEWSWIRE
23 Apr 2018
Share Share